97080 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof Protease inhibitors
Sub-classes:INTER-ALPHA INHIBITOR PROTEINS AND METHODS OF USE THEREOF
#2Methods of Manufacturing Alpha-1 Antitrypsin Compositions For Treatment of Disease Disorders
#3Isolation of Autologous Acellular Biological Therapeutics
#4SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION
#5CULTURE MEDIA FOR CULTURING PLURIPOTENT STEM CELLS IN SUSPENSION
#6SYSTEMS FOR EXTRACTING PROTEINS FROM A BLOOD-BASED MATERIAL
#7PEPTIDE LIBRARY AND USE THEREOF
#8MODIFIED ANTI-INFLAMMATORY PROTEINS AND METHOD OF USE
#9PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF
#10KLK5 INHIBITORY PEPTIDE
#11COMPOSITIONS AND METHODS FOR TREATMENT OF NETHERTON SYNDROME WITH LEKTI EXPRESSING RECOMBINANT MICROBES
#12ULINASTATIN POLYPEPTIDES
#13GLYCOSYLATION OF PROTEINS
#14CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME
#15Fusion proteins comprising an engineered knottin peptide and uses thereof
#16Translatable molecules and synthesis thereof
#17HAPLOID INDUCTION COMPONDS AND METHODS FOR USE THEREOF
#18Methods for Extracting Proteins from a Blood-Based Material
#19TRIPARTITE SYSTEMS FOR PROTEIN DIMERIZATION AND METHODS OF USE
#20KLK5 inhibitory peptide
#21Novel Mechanism to Control RNA Virus Replication and Gene Expression
#22FUSION PROTEIN OF ANTIGEN-BINDING PROTEIN AND FLUORESCENT PROTEIN OR FLUORESCENCE-LABELED TAG PROTEIN
#23Peptides inhibiting KLK1, KLK4, or KLK4 and KLK8
#24Inter-alpha inhibitor proteins
#25METHOD OF TREATING ATHEROSCLEROSIS
#26INTER-ALPHA INHIBITOR PROTEINS AND METHODS OF USE THEREOF
#27COMPOSITIONS AND METHODS FOR DELIVERING TRANSGENES
#28KLK5 inhibitory peptide
#29Ulinastatin polypeptides
#30Glycosylation of proteins
#31Methods for extracting proteins from a blood-based material
#32Fusion proteins comprising an engineered knottin peptide and uses thereof
#33MODIFIED AAV CAPSIDS AND USES THEREOF
#34Modified anti-inflammatory proteins and method of use
#35Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides
#36KLK5 INHIBITORY PEPTIDE
#37Methods for extracting A1P1 and albumin from blood plasma
#38Recombinant adeno-associated viruses encoding serpin peptides and uses thereof
#39INHIBITORS OF THE 20S PROTEASOME
#40Peptide inhibitors of insulin-degrading enzyme
#41Compositions containing HC-HA/PTX3 complexes and methods of use thereof
#42BICYCLIC PEPTIDE LIGAND STING CONJUGATES AND USES THEREOF
#43COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN FUSION MOLECULES
#44Peptides inhibiting KLK1, KLK4, or KLK4 and KLK8
#45Peptide library and use thereof
#46Detection, identification, and purification of degradative and non-degradative enzymes in biological samples
#47Method of treating atherosclerosis
#48Methods and composition for detecting CAPN5
#49Culture media for culturing pluripotent stem cells in suspension
#50GENETICALLY MODIFIED MOUSE MODEL FOR HUMAN HEPATOCYTE XENOTRANSPLANTATION
#51Programmable protein circuits in living cells
#52Compositions containing HC-HA/PTX3 complexes and methods of use thereof
#53METHODS FOR PRODUCING PEPTIDES AND USES THEREOF
#54Methods for extracting proteins from a blood-based material
#55Systems, compositions, and methods for transplantation
#56Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes
#57Peptide having activity to improve skin condition and use thereof
#58Translatable molecules and synthesis thereof
#59PDE4 modulators for treating and preventing immune reconstitution inflammatory syndrome (IRIS)
#60Methods for extracting proteins from blood plasma
#61Intein-modified proteases, their production and industrial applications
#62Method for separating and purifying α2-macroglobulin from Cohn Fraction IV precipitation
#63COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN FUSION MOLECULES
#64Method for clinically and pathologically monitoring Alzheimer's disease through concentration of amyloidbeta in plasma
#65Peptides and uses thereof
#66Process For Isolation of Plasma or Serum Proteins
#67WOUND FLUID ELEVATED PROTEASE ENZYME INHIBITION THROUGH CAMELID BLOOD PRODUCTS
#68Protein biomarkers for immune assessment and prediction of transplant rejection
#69Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#70High-selectivity contact activation inhibitor based on infestin-4
#71Compositions containing HC-HA/PTX3 complexes and methods of use thereof
#72Adeno-associated virus mediated delivery of C1E1 as a therapy for angioedema
#73Modified anti-inflammatory proteins and method of use
#74Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#75BIOMARKERS, METHODS AND KITS FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS
#76Protection against ionizing radiation and chemotherapy toxicity via latexin regulation
#77Process for isolation of plasma or serum proteins
#78METHODS FOR ISOLATING BLOOD PRODUCTS FROM AN INTER-ALPHA INHIBITOR PROTEIN-DEPLETED BLOOD PRODUCT MATERIAL
#79Multiprotein expression cassettes
#80Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
#81Peptide library and use thereof
#82Compositions containing HC-HA/PTX3 complexes and methods of use thereof
#83CYSTEINE PROTEASE CAPTURING AGENTS
#84Transgenic plants with enhanced traits
#85Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)
#86ANTICANCER FUSION PROTEIN
#87Amyloid β-protein-specific production-inhibiting polypeptide
#88Proteinaceous protease inhibitor and protein solution and detergent composition containing it
#89Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
#90POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
#91Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#92Fusion proteins comprising an engineered knottin peptide and uses thereof
#93ANTI-CD14 ANTIBODY FUSION PROTEIN
#94Serpin-finger fusion polypeptide
#95Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis
#96Factor XII inhibitors for treating interstitial lung disease
#97PEPTIDES AND SUPPORTED PEPTIDES FOR TREATING SKIN DISEASES
#98Acceleration Of Wound Healing By A Tissue Inhibitor Of Metalloproteinases (TIMP) Linked To Glycosylphosphatidylinositol (GPI)-Anchors
#99Method for removing a lytic enzyme from a heterogeneous mixture
#100Polynucleotide encoding anti-CD14 antibody fusion protein
#101Antichlamydial agents
#102POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
#103RECOMBINANT PROBIOTIC BACTERIA FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) AND IRRITABLE BOWEL SYNDROME (IBS)
#104Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
#105Compounds useful as protein kinase inhibitors
#106Peptides and Supported Peptides for Treating Skin Diseases
#107RECOMBINANT PREPARATION OF BROMELAIN INHIBITORS AND BROMELAIN INHIBITOR PRECURSOR
#108Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
#109Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome
#110Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
#111ISOLATION AND SEPARATION OF MINIMALLY DENATURED POTATO PROTEINS AND PEPTIDES
#112Inhibitors of Hepatitis C NS3 Protease
#113MYOSIN LIGHT CHAIN KINASE INHIBITORS AND METHODS OF USE
#114Compounds useful as protein kinase inhibitors
#115Expression of heterologous genes according to a targeted expression profile
#116NOVEL ANTICOAGULANT POLYPEPTIDES AND COMPLEX
#117Sericin Having Improved Antioxidant and Tyrosinase Inhibitive Abilities by Irradiation, and Methods of Making and Using the Same
#118CASPASE INHIBITORS, ESPECIALLY CASPASE 3 INHIBITORS, FOR THE TREATMENT OF INFLUENZA
#119Compositions comprising bowman-birk protease inhibitors and variants thereof
#120Caspase-2 inhibitors and their biological applications
#121Anti-CD14 antibody fusion protein
#122FGF-5 Supported and Binding Peptides
#123Binding Domain Fusion Protein
#124Tgfbeta Supported and Binding Peptides
#125Isolation, selection and propagation of animal transgenic stem cells
#126Process for isolation of plasma or serum proteins
#127Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza
#128Targeting compositions and preparation therof
#129Cholesterol biosynthesis pathway modulators and uses thereof
#130Membrane for removing proteases from liquids
#131Pancreas-derived plasminogen activator inhibitor
#132Myosin light chain kinase inhibitors and methods of use
#133Proteases and protease inhibitors
#134Membrane, device and method for removing proteases from liquids
#135FGF-5 supported and binding peptides
#136Novel human protease inhibitor proteins and polynucleotides encoding the same
#137Protein from horn fly saliva that disrupts hemostasis
#138Peptides and supported peptides for treating skin diseases
#139Bacterial expression of bowman-birk protease inhibitors and variants thereof
#140Compounds and methods for identifying compounds which inhibit a new class of aspartyl proteases
#141Isolation, selection and propagation of animal transgenic stem cells
#142Dna vaccine
#143Novel human protease inhibitor proteins and polynucleotides encoding the same
#144Method for controlling the yield and purity of proteinase inhibitor II during extraction
#145Expression cassettes for producing plants with increased levels of essential amino acids
#146Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
#147Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
#148Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
#149Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
#150Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
#151Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
#152Protease inhibitor: protease sensitivity expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria